Ledger.Open graph →
SEC Form D · filed June 14, 2018

Palvella Therapeutics, Inc

Offering
$5.0M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WAYNE, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Todd H. Davis · Wayne, PADirectorMichael H. Christopher · Wayne, PADirectorTimothy H. Henkel · Wayne, PADirectorGeorge H. Jenkins · Wayne, PADirectorElaine H. Heron · Wayne, PADirectorWesley H. Kaupinen · Wayne, PAExec · DirectorJames J. Cunnane, Jr · St. Louis, MODirectorBrandon Alexander · San Carlos, CADirectorJohn T. Karantonis · Norridge, ILDirectorEric D. Chin · San Carlos, CADirectorTom Broussard · Boston, MADirectorAntonios T. Valamontes · Largo, FLExec · DirectorDavid H. Tierney · Wayne, PADirectorMichael Konnert · VANCOUVER, British Columbia, CanadaExec · DirectorCraig Parry · VANCOUVER, British Columbia, CanadaDirectorCharles Funk · VANCOUVER, British Columbia, CanadaDirectorKimberley Yates · Redwood City, CADirectorAlan Hartman · Redwood City, CADirectorMichael Kaplan · Redwood City, CADirectorDavid H. Tierney · Wayne, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗